(lp0
S'Why Stemline Therapeutics Inc Stock Is Climbing Today Motley Fool - Jan 6, 2017 The biotech stock rollercoaster known as Stemline Therapeutics Inc  popped Friday morning with a 21.8% gain, and it was still up about 14.5% as of 11:44 a.m.Stemline Therapeutics  Spikes after announcing FDA Agreement - Economic Calendar'
p1
aS'SHAREHOLDER ALERT: Faruqi &amp; Faruqi, LLP Reminds Investors In Stemline ... PR Newswire  - Mar 24, 2017 NEW YORK, March 23, 2017 /PRNewswire/ -- Faruqi &amp; Faruqi, LLP, a leading national securities law firm, reminds investors in Stemline Therapeutics, Inc.   of the April 4, 2017 deadline to seek the role of lead&nbsp;...'
p2
aS'Stemline Therapeutics Inc  Receives Consensus Recommendation of Buy ... The Cerbat Gem - 19 hours ago Stemline Therapeutics logo Shares of Stemline Therapeutics Inc  have earned an average rating of Buy from the seven analysts that are currently covering the stock.Stemline Therapeutics Inc  Stock Rating Reaffirmed by HC Wainwright - Chaffey Breeze'
p3
aS'Stemline Therapeutics Announces Completion of Enrollment in Stage 3 of the SL ... GlobeNewswire  - Mar 23, 2017 NEW YORK, March 23, 2017  -- Stemline Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics for oncology indications of unmet medical need, announced today that enrollment&nbsp;...'
p4
aS"Stemline Therapeutics Inc.  Plunges 5.03% on March 23 Equities.com - Mar 23, 2017 Stemline Therapeutics Inc.  had a rough trading day for Thursday March 23 as shares tumbled 5.03%, or a loss of $-0.45 per share, to close at $8.50.Stemline Therapeutics Inc  Stock Rating Reaffirmed by Wedbush - The Cerbat GemAnalysts Issue Forecasts for Stemline Therapeutics Inc's FY2020 Earnings  - Chaffey Breeze"
p5
aS'Wolf Popper LLP Announces Investigation on Behalf of Investors in Stemline ... PR Newswire  - Feb 27, 2017 NEW YORK, Feb. 27, 2017 /PRNewswire/ -- Wolf Popper LLP is investigating potential securities fraud claims on behalf of investors in Stemline Therapeutics, Inc. securities  during the period January 6, 2017 through February 1, 2017.'
p6
aS'Shareholder Deadline Reminder : Johnson &amp; Weaver, LLP Announces ... PR Newswire  - Mar 17, 2017 SAN DIEGO, March 17, 2017 /PRNewswire/ -- Shareholder Rights Law Firm Johnson &amp; Weaver, LLP  announces the filing of a class action lawsuit on behalf of purchasers of Stemline Therapeutics, Inc.  between January 6, 2017 and&nbsp;...Stemline Therapeutics,Inc.  Files An 8-K Results of Operations ... - Market ExclusiveHot Stocks Report: Kopin Corporation , Stemline Therapeutics, Inc.  - Post Analyst'
p7
aS"Stemline Therapeutics Inc.  Soars 14.29% on March 01 Equities.com - Mar 1, 2017 Stemline Therapeutics Inc.  had a good day on the market for Wednesday March 01 as shares jumped 14.29% to close at $8.00.Here's Why Stemline Therapeutics Inc 's Shares Soared Despite ... - StockNewsUnionStemline Therapeutics Inc  CAO David Gionco Sells 3500 Shares - Chaffey Breeze"
p8
aS'Stemline Therapeutics Inc.  Soars 7.98% on March 09 Equities.com - Mar 9, 2017 Stemline Therapeutics Inc.  had a good day on the market for Thursday March 09 as shares jumped 7.98% to close at $8.80.14 hedge funds buy Stemline Therapeutics, Inc.  for the first time - Post AnalystThe Stemline Therapeutics Inc  COO Kenneth Hoberman Sells 4000 Shares - DailyQuint'
p9
aS'QI Valuation Update on Stemline Therapeutics, Inc.  Business Review - Mar 27, 2017 Typically, the lower the value, the more undervalued the company tends to be. Stemline Therapeutics, Inc.  currently has a Q.i.'
p10
a.